A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
Convalescent plasma is frequently administered to patients with Covid-19 and has been reported, largely on the basis of observational data, to improve clinical outcomes. Minimal data are available from adequately powered randomized, controlled trials.
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
Size: 608 KB
9 Downloads